Trial intelligence / Profile preview

Bromfenac as Adjunct to Argon Laser Therapy for Diabetic Macular Edema

NCT00758628Phase 4Completed

Sponsor
BP Consulting
Start
Aug 2008
Primary completion
May 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bromfenac sodium in diabetic macular edema (DME), sponsored by BP Consulting. Started Aug 2008; status: completed.

02

Drugs

bromfenac sodium
03

Conditions

diabetic macular edema (DME)

Beyond the preview

Go deeper on NCT00758628.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00758628.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call